Flavio Vincenti, MD

Antiplasma cell antibodies: A new era of human leukocyte antigen antibody control in solid organ transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Chandran S, Vincenti F

Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Torija A, Matignon M, Vincenti F, Casanova-Ferrer F, Pilon C, Tambur AR, Donadeu L, Crespo E, Kervella D, Meneghini M, Torres IB, Hafkamp F, Martinez-Lacalle A, Carrera C, Zúñiga J, Brar A, Cruzado J, Gaber AO, Lee H, Montgomery RA, Stegall M, Carmagnat M, Usureau C, Moreso F, Grimbert P, Bestard O

Poised for Innovation: Considerations for End Points for New Drug Development in Kidney Transplantation.

Journal of the American Society of Nephrology : JASN

Mannon RB, Vincenti F

Long-term Safety in Epstein-Barr Virus-Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry.

Transplantation direct

Larsen CP, Vincenti F, D Kou T, Shadur CA, Bresnahan B, Jordan SC, Woodle ES, Goes N, Vella J, Wojciechowski D, Polinsky MS, Gomez-Caminero A

The hepatocyte growth factor mimetic, ANG-3777, in kidney transplant recipients with delayed graft function: results from a randomized phase 3 trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Bromberg J, Kim J, Faravardeh A, Leca N, Alperovich G, Csomor PA, Aslam S, Neylan J

Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.

Journal of the American Society of Nephrology : JASN

Vincenti F, Bestard O, Brar A, Cruzado JM, Seron D, Gaber AO, Ali N, Tambur AR, Lee H, Abbadessa G, Paul JA, Dudek M, Siegel RJ, Torija A, Semiond D, Lépine L, Ternes N, Montgomery RA, Stegall M

State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs.

Frontiers in immunology

Vincenti F, Angeletti A, Ghiggeri GM

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial.

JAMA

Limaye AP, Budde K, Humar A, Vincenti F, Kuypers DRJ, Carroll RP, Stauffer N, Murata Y, Strizki JM, Teal VL, Gilbert CL, Haber BA

Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses.

Cell reports

Duan M, Nguyen DC, Joyner CJ, Saney CL, Tipton CM, Andrews J, Lonial S, Kim C, Hentenaar I, Kosters A, Ghosn E, Jackson A, Knechtle S, Maruthamuthu S, Chandran S, Martin T, Rajalingam R, Vincenti F, Breeden C, Sanz I, Gibson G, Lee FE

Open letter to Bristol Myers Squibb: belatacept; we aren't done yet.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Budde K, Grinyo J, Rostaing L, Kirk AD, Larsen CP

Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study.

BMJ (Clinical research ed.)

Raynaud M, Al-Awadhi S, Juric I, Divard G, Lombardi Y, Basic-Jukic N, Aubert O, Dubourg L, Masson I, Mariat C, Prié D, Pernin V, Le Quintrec M, Larson TS, Stegall MD, Bikbov B, Ruggenenti P, Mesnard L, Ibrahim HN, Nielsen MB, Matas AJ, Nankivell BJ, Benjamens S, Pol RA, Bakker SJL, Jouven X, Legendre C, Kamar N, Smith BH, Wadei HM, Durrbach A, Vincenti F, Remuzzi G, Lefaucheur C, Bentall AJ, Loupy A

Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factors.

Annals of translational medicine

Rashmi P, Sigdel TK, Rychkov D, Damm I, Da Silva AA, Vincenti F, Lourenco AL, Craik CS, Reiser J, Sarwal MM

Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell Analyses.

bioRxiv : the preprint server for biology

Duan M, Nguyen DC, Joyner CJ, Saney CL, Tipton CM, Andrews J, Lonial S, Kim C, Hentenaar I, Kosters A, Ghosn E, Jackson A, Knechtle S, Maruthamuthu S, Chandran S, Martin T, Rajalingam R, Vincenti F, Breeden C, Sanz I, Gibson G, Eun-Hyung Lee F

Burden of neutropenia and leukopenia among adult kidney transplant recipients: A systematic literature review of observational studies.

Transplant infectious disease : an official journal of the Transplantation Society

Raval AD, Kistler KD, Tang Y, Vincenti F

Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients.

Transplantation direct

Looney CM, Schroeder A, Tavares E, Garg J, Schindler T, Vincenti F, Redfield RR, Jordan SC, Busque S, Woodle ES, Khan J, Eastham J, Micallef S, Austin CD, Morimoto A

Infliximab Induction Lacks Efficacy and Increases BK Virus Infection in Deceased Donor Kidney Transplant Recipients.

Journal of the American Society of Nephrology : JASN

Hricik D, Armstrong B, Alhamad T, Brennan D, Bromberg J, Bunnapradist S, Chandran S, Fairchild R, Foley D, Formica R, Gibson I, Kesler K, Kim SJ, Mannon R, Menon M, Newell K, Nickerson P, Odim J, Poggio E, Sung R, Shapiro R, Tinckam K, Vincenti F, Heeger P

Outcomes among CMV-mismatched and highly sensitized kidney transplants recipients who develop neutropenia.

Clinical transplantation

Brar S, Berry R, Raval AD, Tang Y, Vincenti F, Skartsis N

IL-6 and TNFa Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function.

Frontiers in immunology

Skartsis N, Peng Y, Ferreira LMR, Nguyen V, Ronin E, Muller YD, Vincenti F, Tang Q

Conversion from Calcineurin Inhibitor to Belatacept-based Maintenance Immunosuppression in Renal Transplant Recipients: a Randomized Phase 3b Trial.

Journal of the American Society of Nephrology : JASN

Budde K, Prashar R, Haller H, Rial M, Kamar N, Agarwal A, de Fijter J, Rostaing L, Berger S, Djamali A, Leca N, Allamassey L, Gao S, Polinsky M, Vincenti F

Application of the iBox prognostication system as a surrogate endpoint in the TRANSFORM randomised controlled trial: proof-of-concept study.

BMJ open

Aubert O, Divard G, Pascual J, Oppenheimer F, Sommerer C, Citterio F, Tedesco H, Chadban S, Henry M, Vincenti F, Srinivas T, Watarai Y, Legendre C, Bernhardt P, Loupy A

Tests for the non-invasive diagnosis of kidney transplant rejection should be evaluated by kidney transplant programs.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Danovitch G, Bunnapradist S, Cohen D, Hariharan S, McKay D, Ratner L, Stegall M, Steiner R, Stock P, Vincenti F

A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells.

Frontiers in immunology

Lee LM, Zhang H, Lee K, Liang H, Merleev A, Vincenti F, Maverakis E, Thomson AW, Tang Q

Interleukin-6 Blockade with Tocilizumab Increases Tregs and Reduces T Effector Cytokines in Renal Graft Inflammation: A Randomized Controlled Trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Chandran S, Leung J, Hu C, Laszik ZG, Tang Q, Vincenti FG

Single-Cell RNA Sequencing of Tocilizumab-Treated Peripheral Blood Mononuclear Cells as an in vitro Model of Inflammation.

Frontiers in genetics

Zarinsefat A, Hartoularos G, Rychkov D, Rashmi P, Chandran S, Vincenti F, Yee CJ, Sarwal MM

Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Kirk AD, Adams AB, Durrbach A, Ford ML, Hildeman DA, Larsen CP, Vincenti F, Wojciechowski D, Woodle ES

Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function.

Kidney international reports

Vincenti F, Kim J, Gouveia D, Pelle G, Mayne TJ, Neylan JF

The impact of belatacept on the phenotypic heterogeneity of renal T cell-mediated alloimmune response: the critical role of maintenance treatment and inflammatory load.

Clinical transplantation

Dobi D, Vincenti F, Chandran S, Greenland JR, Bowman C, Chen A, Henrik J, Laszik ZG

Single-cell RNA sequencing of Tocilizumab-treated peripheral blood mononuclear cells as an in vitro model of inflammation.

bioRxiv : the preprint server for biology

Zarinsefat A, Hartoularos G, Yee CJ, Sarwal MM

A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection.

Science translational medicine

Yang JYC, Sarwal RD, Sigdel TK, Damm I, Rosenbaum B, Liberto JM, Chan-On C, Arreola-Guerra JM, Alberu J, Vincenti F, Sarwal MM

Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes.

Transplantation

Harel E, Shoji J, Abraham V, Miller L, Laszik ZG, King A, Dobi D, Szabo G, Hann B, Sarwal MM, Craik CS, Vincenti F

Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies.

Frontiers in medicine

Sigdel T, Nguyen M, Liberto J, Dobi D, Junger H, Vincenti F, Laszik Z, Sarwal MM

A randomized, phase 1b study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of bleselumab, a fully human, anti-CD40 monoclonal antibody, in kidney transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Klintmalm G, Yang H, Ram Peddi V, Blahunka P, Conkle A, Santos V, Holman J

Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients.

Transplantation reviews (Orlando, Fla.)

Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H

Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Redfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, Schroeder A, Cascino MD, Brunetta P, Borie D

Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J

Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing.

Nature communications

Pineda S, Sigdel TK, Liberto JM, Vincenti F, Sirota M, Sarwal MM

Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation.

Clinical transplantation

Harel E, Shoji J, Abraham V, Miller L, Laszik Z, Thurison T, King A, Olshen A, Leung J, Szabo G, Hann B, Høyer-Hansen G, Craik CS, Vincenti F

Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial.

Transplantation direct

Busque S, Vincenti FG, Tedesco Silva H, O'Connell PJ, Yoshida A, Friedewald JJ, Steinberg SM, Budde K, Broeders EN, Kim YS, Hahn CM, Li H, Chan G

Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial.

Transplantation direct

Webber AB, Tatapudi V, Maw TT, Peralta C, Leung JCY, Vincenti F

A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Budde K, Merville P, Shihab F, Ram Peddi V, Shah M, Wyburn K, Cassuto-Viguier E, Weidemann A, Lee M, Flegel T, Erdman J, Wang X, Lademacher C

Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

Journal of the American Society of Nephrology : JASN

Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F

Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients administered belatacept or cyclosporine in BENEFIT and BENEFIT-EXT.

Clinical transplantation

Florman S, Vincenti F, Durrbach A, Abouljoud M, Bresnahan B, Garcia VD, Mulloy L, Rice K, Rostaing L, Zayas C, Calderon K, Meier-Kriesche U, Polinsky M, Yang L, Medina Pestana J, Larsen CP

Targeted Transcriptional Profiling of Kidney Transplant Biopsies.

Kidney international reports

Sigdel TK, Nguyen M, Dobi D, Hsieh SC, Liberto JM, Vincenti F, Sarwal MM, Laszik Z

Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients.

Transplantation proceedings

Wojciechowski D, Chandran S, Webber A, Hirose R, Vincenti F

Ten-year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4-weekly or 8-weekly.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Blancho G, Durrbach A, Grannas G, Grinyó J, Meier-Kriesche HU, Polinsky M, Yang L, Larsen CP

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Chandran S, Tang Q, Sarwal M, Laszik ZG, Putnam AL, Lee K, Leung J, Nguyen V, Sigdel T, Tavares EC, Yang JYC, Hellerstein M, Fitch M, Bluestone JA, Vincenti F

Retrospective evaluation of the efficacy and safety of belatacept with thymoglobulin induction and maintenance everolimus: A single-center clinical experience.

Clinical transplantation

Wojciechowski D, Chandran S, Yang JYC, Sarwal MM, Vincenti F

Transplant trials with Tregs: perils and promises.

The Journal of clinical investigation

Tang Q, Vincenti F

B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Asare A, Kanaparthi S, Lim N, Phippard D, Vincenti F, Friedewald J, Pavlakis M, Poggio E, Heeger P, Mannon R, Burrell BE, Morrison Y, Bridges N, Sanz I, Chandraker A, Newell KA, Turka LA

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.

Kidney international reports

Vincenti F, Fervenza FC, Campbell KN, Diaz M, Gesualdo L, Nelson P, Praga M, Radhakrishnan J, Sellin L, Singh A, Thornley-Brown D, Veronese FV, Accomando B, Engstrand S, Ledbetter S, Lin J, Neylan J, Tumlin J

Belatacept: the challenges with transformational drugs.

Translational andrology and urology

Vincenti F

Early post-transplant conversion from tacrolimus to belatacept for prolonged delayed graft function improves renal function in kidney transplant recipients.

Clinical transplantation

Wojciechowski D, Chandran S, Vincenti F

Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Grinyó JM, Del Carmen Rial M, Alberu J, Steinberg SM, Manfro RC, Nainan G, Vincenti F, Jones-Burton C, Kamar N

Current status of costimulatory blockade in renal transplantation.

Current opinion in nephrology and hypertension

Wojciechowski D, Vincenti F

Costimulatory Blockade and Use of mTOR Inhibitors: Avoiding Injury Part 2.

Advances in chronic kidney disease

Wojciechowski D, Vincenti F

Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Klintmalm GB, Vincenti F, Kirk A

Belatacept and Long-Term Outcomes in Kidney Transplantation.

The New England journal of medicine

Vincenti F

An Update on Calcineurin Inhibitor-Free Regimens: The Need Persists, but the Landscape has Changed.

Transplantation

Webber AB, Vincenti F

Belatacept and Long-Term Outcomes in Kidney Transplantation.

The New England journal of medicine

Vincenti F, Rostaing L, Grinyo J, Rice K, Steinberg S, Gaite L, Moal MC, Mondragon-Ramirez GA, Kothari J, Polinsky MS, Meier-Kriesche HU, Munier S, Larsen CP

A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.

Transplantation

Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F

A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts.

PloS one

Sigdel TK, Bestard O, Tran TQ, Hsieh SC, Roedder S, Damm I, Vincenti F, Sarwal MM

Evaluation of the effect of tofacitinib exposure on outcomes in kidney transplant patients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Silva HT, Busque S, O'Connell PJ, Russ G, Budde K, Yoshida A, Tortorici MA, Lamba M, Lawendy N, Wang W, Chan G

The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.

PLoS medicine

Roedder S, Sigdel T, Salomonis N, Hsieh S, Dai H, Bestard O, Metes D, Zeevi A, Zeevi A, Gritsch A, Cheeseman J, Macedo C, Peddy R, Medeiros M, Vincenti F, Asher N, Salvatierra O, Shapiro R, Kirk A, Reed EF, Reed E, Sarwal MM

Role of podocyte B7-1 in diabetic nephropathy.

Journal of the American Society of Nephrology : JASN

Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D'Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH

Clinical aspects: focusing on key unique organ-specific issues of renal transplantation.

Cold Spring Harbor perspectives in medicine

Chandran S, Vincenti F

Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Rostaing L, Vincenti F, Grinyó J, Rice KM, Bresnahan B, Steinberg S, Gang S, Gaite LE, Moal MC, Mondragón-Ramirez GA, Kothari J, Pupim L, Larsen CP

Tofacitinib in kidney transplantation.

Expert opinion on investigational drugs

Wojciechowski D, Vincenti F

Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharma.

Transplant international : official journal of the European Society for Organ Transplantation

van Gelder T, Baan C, Vincenti F, Mannon RB

Native renal function after combined liver-kidney transplant for type 1 hepatorenal syndrome: initial report on the use of postoperative Technetium-99 m-mercaptoacetyltriglycine scans.

Transplant international : official journal of the European Society for Organ Transplantation

Vagefi PA, Qian JJ, Carlson DM, Aparici CM, Hirose R, Vincenti F, Wojciechowski D

Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.

Transplantation

Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F

Belatacept in kidney transplantation.

Current opinion in organ transplantation

Wojciechowski D, Vincenti F

Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, Scheuermann EH, Klinger M, Russ G, Pescovitz MD, Prestele H

Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update.

Biologics : targets & therapy

Wojciechowski D, Vincenti F

Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients.

Transplant international : official journal of the European Society for Organ Transplantation

Tang Q, Leung J, Melli K, Lay K, Chuu EL, Liu W, Bluestone JA, Kang SM, Peddi VR, Vincenti F

Improvement in renal function in kidney transplant recipients switched from cyclosporine or tacrolimus to belatacept: 2-year results from the long-term extension of a phase II study.

Transplant international : official journal of the European Society for Organ Transplantation

Grinyo J, Alberu J, Contieri FL, Manfro RC, Mondragon G, Nainan G, Rial Mdel C, Steinberg S, Vincenti F, Dong Y, Thomas D, Kamar N

Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Tedesco Silva H, Busque S, O'Connell P, Friedewald J, Cibrik D, Budde K, Yoshida A, Cohney S, Weimar W, Kim YS, Lawendy N, Lan SP, Kudlacz E, Krishnaswami S, Chan G

Are calcineurin inhibitors-free regimens ready for prime time?

Kidney international

Vincenti F

Beyond belatacept: praise and progress for the FDA.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F

Targeting JAK3 in kidney transplantation: current status and future options.

Current opinion in organ transplantation

Wojciechowski D, Vincenti F

C4d/CD34 double-immunofluorescence staining of renal allograft biopsies for assessing peritubular capillary C4d positivity.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Jen KY, Nguyen TB, Vincenti FG, Laszik ZG

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Larsen CP, Alberu J, Bresnahan B, Garcia VD, Kothari J, Lang P, Urrea EM, Massari P, Mondragon-Ramirez G, Reyes-Acevedo R, Rice K, Rostaing L, Steinberg S, Xing J, Agarwal M, Harler MB, Charpentier B

Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes.

Clinical journal of the American Society of Nephrology : CJASN

Rostaing L, Neumayer HH, Reyes-Acevedo R, Bresnahan B, Florman S, Vitko S, Heifets M, Xing J, Thomas D, Vincenti F

Belatacept.

Nature reviews. Drug discovery

Vincenti F, Dritselis A, Kirkpatrick P

Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation.

Seminars in immunology

Wojciechowski D, Vincenti F

Novel strategies in immunosuppression: issues in perspective.

Transplantation

Webber A, Hirose R, Vincenti F

Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies).

Transplantation

Vanrenterghem Y, Bresnahan B, Campistol J, Durrbach A, Grinyó J, Neumayer HH, Lang P, Larsen CP, Mancilla-Urrea E, Pestana JM, Block A, Duan T, Glicklich A, Gujrathi S, Vincenti F

Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Friman S, Arns W, Nashan B, Vincenti F, Banas B, Budde K, Cibrik D, Chan L, Klempnauer J, Mulgaonkar S, Nicholson M, Wahlberg J, Wissing KM, Abrams K, Witte S, Woodle ES

A phase 1, single-dose study of fresolimumab, an anti-TGF-ß antibody, in treatment-resistant primary focal segmental glomerulosclerosis.

Kidney international

Trachtman H, Fervenza FC, Gipson DS, Heering P, Jayne DR, Peters H, Rota S, Remuzzi G, Rump LC, Sellin LK, Heaton JP, Streisand JB, Hard ML, Ledbetter SR, Vincenti F

Response to questions regarding the design and results of the IMPACT trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Humar A, Peeters P, Abramowicz D, Humar A, Lebranchu Y, Hauser I, Jardine A, Limaye AP, Vincenti F, Punch JD, Blumberg E

An integrated safety profile analysis of belatacept in kidney transplant recipients.

Transplantation

Grinyó J, Charpentier B, Pestana JM, Vanrenterghem Y, Vincenti F, Reyes-Acevedo R, Apanovitch AM, Gujrathi S, Agarwal M, Thomas D, Larsen CP

Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies.

Transplantation

Larsen CP, Grinyó J, Medina-Pestana J, Vanrenterghem Y, Vincenti F, Breshahan B, Campistol JM, Florman S, Rial Mdel C, Kamar N, Block A, Di Russo G, Lin CS, Garg P, Charpentier B

Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study.

Transplantation

Humar A, Limaye AP, Blumberg EA, Hauser IA, Vincenti F, Jardine AG, Abramowicz D, Ives JA, Farhan M, Peeters P

Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.

Transplantation

Posselt AM, Szot GL, Frassetto LA, Masharani U, Tavakol M, Amin R, McElroy J, Ramos MD, Kerlan RK, Fong L, Vincenti F, Bluestone JA, Stock PG

How the development of new biological agents may help minimize immunosuppression in kidney transplantation: the impact of belatacept.

Current opinion in organ transplantation

Wojciechowski D, Vincenti F

Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Ferguson R, Grinyó J, Vincenti F, Kaufman DB, Woodle ES, Marder BA, Citterio F, Marks WH, Agarwal M, Wu D, Dong Y, Garg P

Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.

Clinical journal of the American Society of Nephrology : CJASN

Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G, Thomas D, Grinyó J

Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) database.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S

Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Posselt AM, Bellin MD, Tavakol M, Szot GL, Frassetto LA, Masharani U, Kerlan RK, Fong L, Vincenti FG, Hering BJ, Bluestone JA, Stock PG

Five-year safety and efficacy of belatacept in renal transplantation.

Journal of the American Society of Nephrology : JASN

Vincenti F, Blancho G, Durrbach A, Friend P, Grinyo J, Halloran PF, Klempnauer J, Lang P, Larsen CP, Mühlbacher F, Nashan B, Soulillou JP, Vanrenterghem Y, Wekerle T, Agarwal M, Gujrathi S, Shen J, Shi R, Townsend R, Charpentier B

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP, Abramowicz D, Jardine AG, Voulgari AT, Ives J, Hauser IA, Peeters P

A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Durrbach A, Pestana JM, Pearson T, Vincenti F, Garcia VD, Campistol J, Rial Mdel C, Florman S, Block A, Di Russo G, Xing J, Garg P, Grinyó J

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin CS, Garg P, Larsen CP

Kidney transplantation at UCSF: 8,300 transplants and onward.

Clinical transplants

Wojciechowski D, Hirose R, Stock P, Vincenti F, Baxter-Lowe LA, Salvatierra O

Novel B cell therapeutic targets in transplantation and immune-mediated glomerular diseases.

Clinical journal of the American Society of Nephrology : CJASN

Vincenti F, Cohen SD, Appel G

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

Kidney international

Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM

Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Busque S, Leventhal J, Brennan DC, Steinberg S, Klintmalm G, Shah T, Mulgaonkar S, Bromberg JS, Vincenti F, Hariharan S, Slakey D, Peddi VR, Fisher RA, Lawendy N, Wang C, Chan G

Kidney transplantation: the ideal immunosuppression regimen.

Advances in chronic kidney disease

Yabu JM, Vincenti F

Transplantation: To convert or not to convert: lessons from the CONVERT trial.

Nature reviews. Nephrology

Bunnapradist S, Vincenti F

The AST's perspective on the proposed kidney allocation system.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Murphy B, Vincenti F, Meier-Kriesche HU

The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study.

Transplantation

Ekberg H, Mamelok RD, Pearson TC, Vincenti F, Tedesco-Silva H, Daloze P

Long-term renal function and cardiovascular disease risk in obese kidney donors.

Clinical journal of the American Society of Nephrology : CJASN

Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM

Evolving trends in induction therapy.

Transplantation reviews (Orlando, Fla.)

Arias M, Campistol JM, Vincenti F

Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation.

Transplantation

Latek R, Fleener C, Lamian V, Kulbokas E, Davis PM, Suchard SJ, Curran M, Vincenti F, Townsend R

Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients.

Clinical pharmacokinetics

Kuypers DR, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok RD, Bouw RM

The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Bluestone JA, Liu W, Yabu JM, Laszik ZG, Putnam A, Belingheri M, Gross DM, Townsend RM, Vincenti F

What's next in the pipeline.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Kirk AD

Tolerance versus immunosuppression: a perspective.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Halloran PF, Bromberg J, Kaplan B, Vincenti F

Association of four DNA polymorphisms with acute rejection after kidney transplantation.

Transplant international : official journal of the European Society for Organ Transplantation

Grinyó J, Vanrenterghem Y, Nashan B, Vincenti F, Ekberg H, Lindpaintner K, Rashford M, Nasmyth-Miller C, Voulgari A, Spleiss O, Truman M, Essioux L

Open letter to the FDA: new drug trials must be relevant.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Klintmalm G, Halloran PF

A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J

Costimulation blockade in autoimmunity and transplantation.

The Journal of allergy and clinical immunology

Vincenti F

Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study. Am J Transplant 7, 560-570, 2007.

Clinical journal of the American Society of Nephrology : CJASN

Ekberg H, Grinyo J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M, CAESAR study group

Proteomics of plasma and urine in primary nephrotic syndrome in children.

Contributions to nephrology

Candiano G, Musante L, Petretto A, Bruschi M, Santucci L, Urbani A, Scolari F, Gusmano R, Carraro M, Zennaro C, Vincenti F, Ghiggeri GM

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7 1506-1514, 2007.

Clinical journal of the American Society of Nephrology : CJASN

Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Viecek A, Chadban S, El-Shahawy M, Budde K, Goto N, DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C2 Monitoring Versus Tacrolimus) inve

Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Yabu JM, Ho B, Scandling JD, Vincenti F

A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Mendez R, Pescovitz M, Rajagopalan PR, Wilkinson AH, Butt K, Laskow D, Slakey DP, Lorber MI, Garg JP, Garovoy M

Novel immunosuppression: small molecules and biologics.

Seminars in nephrology

Yabu JM, Vincenti F

Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.

British journal of clinical pharmacology

Pescovitz MD, Vincenti F, Hart M, Melton L, Whelchel J, Mulgaonkar S, McKay D, Leung M, Calleja E, Bouw MR

Costimulation blockade--what will the future bring?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Vincenti F

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, El-Shahawy M, Budde K, Goto N

Sirolimus: defining nephrotoxicity in the renal transplant recipient.

Clinical journal of the American Society of Nephrology : CJASN

Tomlanovich SJ, Vincenti F

Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin.

Journal of the American Society of Nephrology : JASN

Musante L, Candiano G, Petretto A, Bruschi M, Dimasi N, Caridi G, Pavone B, Del Boccio P, Galliano M, Urbani A, Scolari F, Vincenti F, Ghiggeri GM

Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Ekberg H, Grinyó J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M

T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation.

Annual review of medicine

Vincenti F, Luggen M

Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature.

Transplantation

Arns W, Cibrik DM, Walker RG, Mourad G, Budde K, Mueller EA, Vincenti F

Living donor kidney transplant recipients and clinical trials: participation profiles and impact on post-transplant care.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Brennan TV, Fuller TF, Vincenti F, Chan S, Chang CK, Bostrom A, Zlatunich JK, Tomlanovich SJ, Feng S

Immunosuppression: today, tomorrow, and withdrawal.

Seminars in liver disease

Hirose R, Vincenti F

Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients.

Transplant international : official journal of the European Society for Organ Transplantation

Vincenti F, de Andrés A, Becker T, Choukroun G, Cole E, González-Posada JM, Kumar MA, Moore R, Nadalin S, Nashan B, Rostaing L, Saito K, Yoshimura N

Antibodies come back to the forefront in transplantation.

Clinical journal of the American Society of Nephrology : CJASN

Vincenti F

A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients.

Transplantation

Vincenti F, Mendez R, Curtis J, Light J, Pearson T, Wu YM, Katz SM, Akalin E, Esterl R, Gugliuzza K, Shihab F, Jordan S, Jonsson J, Molmenti E, Barbeito R

Toxicity-sparing protocols using mycophenolate mofetil in renal transplantation.

Transplantation

Land W, Vincenti F

Current use and future trends in induction therapy.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Vincenti F

Rapidly developing nephrocalcinosis in a patient with end-stage liver disease who received a domino liver transplant from a patient with known congenital oxalosis.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine

Aziz S, Callen PW, Vincenti F, Hirose R

Costimulation blockade with belatacept in renal transplantation.

The New England journal of medicine

Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B

A drug of the past, a lesson for the future.

Pediatric transplantation

Vincenti F

Guidelines for the treatment and management of new-onset diabetes after transplantation.

Clinical transplantation

Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa JV, Uchida K, Valantine H, Villamil F, Vincenti F, Wissing M

New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Ghiggeri GM

Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation.

Transplantation proceedings

Vincenti F, Tuncer M, Castagneto M, Klinger M, Friman S, Scheuermann EH, Wiecek A, Russ GR, Martinek A, Nonnast-Daniel B

An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency.

Clinical transplantation

Peddi VR, Jensik S, Pescovitz M, Pirsch J, Adler SH, Thistlethwaite JR, Vincenti F, Cohen DJ

Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.

Contemporary clinical trials

Vincenti F, Rostaing L

A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Woodle ES, Vincenti F, Lorber MI, Gritsch HA, Hricik D, Washburn K, Matas AJ, Gallichio M, Neylan J

Chronic induction. What's new in the pipeline.

Contributions to nephrology

Vincenti F

BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Lipshutz GS, Flechner SM, Govani MV, Vincenti F

Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients.

Transplant international : official journal of the European Society for Organ Transplantation

Vincenti F

Infliximab in the treatment of steroid-dependent ulcerative colitis.

European review for medical and pharmacological sciences

Armuzzi A, De Pascalis B, Lupascu A, Fedeli P, Leo D, Mentella MC, Vincenti F, Melina D, Gasbarrini G, Pola P, Gasbarrini A

A decade of progress in kidney transplantation.

Transplantation

Vincenti F

Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Ghiggeri GM, Carraro M, Vincenti F

Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys.

Transplantation proceedings

Vincenti F, Brennan TV, Fuller TF, Feng S

Retransplantation in patients with graft loss caused by polyoma virus nephropathy.

Transplantation

Ramos E, Vincenti F, Lu WX, Shapiro R, Trofe J, Stratta RJ, Jonsson J, Randhawa PS, Drachenberg CB, Papadimitriou JC, Weir MR, Wali RK

Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation.

Clinical transplantation

Pescovitz MD, Bumgardner G, Gaston RS, Kirkman RL, Light S, Patel IH, Nieforth K, Vincenti F

CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.

Transplantation

Posselt AM, Vincenti F, Bedolli M, Lantz M, Roberts JP, Hirose R

Immunosuppression minimization: current and future trends in transplant immunosuppression.

Journal of the American Society of Nephrology : JASN

Vincenti F

Prevalence and management of anemia in renal transplant recipients: a European survey.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F

De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco.

Transplantation proceedings

Vincenti F, Stock P

Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A

New monoclonal antibodies in renal transplantation.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology

Vincenti F

Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F, Pace D, Birnbaum J, Lantz M

What's in the pipeline? New immunosuppressive drugs in transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Vincenti F

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years.

Transplantation

Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J

Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: a preliminary evaluation.

Journal of clinical pharmacology

Parasrampuria DA, Lantz MV, Birnbaum JL, Vincenti FG, Benet LZ

Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens.

Transplantation proceedings

Vincenti F

Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.

Transplantation

Bumgardner GL, Hardie I, Johnson RW, Lin A, Nashan B, Pescovitz MD, Ramos E, Vincenti F

Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function.

Transplantation

Bumgardner GL, Ramos E, Lin A, Vincenti F

Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen.

Transplantation proceedings

Vincenti F

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

Transplantation

Vincenti F, Ramos E, Brattstrom C, Cho S, Ekberg H, Grinyo J, Johnson R, Kuypers D, Stuart F, Khanna A, Navarro M, Nashan B

Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation.

Transplantation proceedings

Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Neylan J, Roza A, Somberg K

Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial.

Transplantation proceedings

Vincenti F

The role of newer monoclonal antibodies in renal transplantation.

Transplantation proceedings

Vincenti F

Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors.

Transplantation

Norman DJ, Vincenti F, de Mattos AM, Barry JM, Levitt DJ, Wedel NI, Maia M, Light SE

A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.

Clinical transplantation

Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R

Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability.

Journal of clinical pharmacology

Pirsch J, Bekersky I, Vincenti F, Boswell G, Woodle ES, Alak A, Kruelle M, Fass N, Facklam D, Mekki Q

The role of daclizumab in balancing resources for inpatient and outpatient transplant services.

Progress in transplantation (Aliso Viejo, Calif.)

Korsun A, Vincenti F, Ruck D, Whitelaw N, Ladoulis C, Whitelaw G

Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis.

Transplant international : official journal of the European Society for Organ Transplantation

Ekberg H, Bäckman L, Tufveson G, Tydén G, Nashan B, Vincenti F

Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).

Transplantation

Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V

Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation.

Transplantation proceedings

Vincenti F

Potential of daclizumab in solid organ transplantation.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Vincenti F

Can antibody prophylaxis allow sparing of other immunosuppressives?

Transplantation proceedings

Vincenti F, Grinyo J, Ramos E, Nashan B, Stuart F, Kuypers D, Brattstrom C, Cho S, Ekberg H, Johnson R

Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry.

Transplantation proceedings

Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz C, Roza AM, Vincenti F, George V

Review of transplantation--1999.

Clinical transplants

Hirose R, Vincenti F

Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.

Transplantation

Solez K, Vincenti F, Filo RS

Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups.

Transplantation proceedings

Vincenti F, Nashan B, Light S

Single-center long-term results of renal transplantation for IgA nephropathy.

Transplantation

Bumgardner GL, Amend WC, Ascher NL, Vincenti FG

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

The New England journal of medicine

Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J

Selection strategies for successful utilization of less than 15.kg pediatric donor kidneys.

Transplantation proceedings

Bretan PN, Freise C, Goldstein R, Osorio R, Tomlanovich S, Amend W, Mathur V, Vincenti F

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.

Transplantation

Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS

FK 506 in kidney transplantation: results of the U.S.A. randomized comparative phase III study. The FK 506 Kidney Transplant Study Group.

Transplantation proceedings

Miller J, Pirsch JD, Deierhoi M, Vincenti F, Filo RS

Immunologic and patient selection strategies for successful utilization of less than 15 kg pediatric donor kidneys--long term experiences with 40 transplants.

Transplantation

Bretan PN, Friese C, Goldstein RB, Osorio RW, Tomlanovich S, Amend W, Mathur V, Vincenti F

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation.

Transplantation

Vincenti F, Lantz M, Birnbaum J, Garovoy M, Mould D, Hakimi J, Nieforth K, Light S

An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group.

Transplantation

Laskow DA, Vincenti F, Neylan JF, Mendez R, Matas AJ

A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.

Transplantation

Woodle ES, Thistlethwaite JR, Gordon JH, Laskow D, Deierhoi MH, Burdick J, Pirsch JD, Sollinger H, Vincenti F, Burrows L, Schwartz B, Danovitch GM, Wilkinson AH, Shaffer D, Simpson MA, Freeman RB, Rohrer RJ, Mendez R, Aswad S, Munn SR, Wiesner RH, Delmonico FL, Neylan J, Whelchel J

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group.

Transplantation

Vincenti F, Laskow DA, Neylan JF, Mendez R, Matas AJ

Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

The New England journal of medicine

Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F

In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.

Transplantation proceedings

Stock PG, Lantz M, Light S, Vincenti F

Pentoxifylline does not prevent the cytokine-induced first dose reaction following OKT3--a randomized, double-blind placebo-controlled study.

Transplantation

Vincenti F, Danovitch GM, Neylan JF, Steiner RW, Everson MP, Gaston RS

Fibrosing cholestatic hepatitis in renal transplant recipients.

Transplantation

Lam PW, Wachs ME, Somberg KA, Vincenti F, Lake JR, Ferrell LD

Histopathological concordance of paired renal allograft biopsy cores. Effect on the diagnosis and management of acute rejection.

Transplantation

Sorof JM, Vartanian RK, Olson JL, Tomlanovich SJ, Vincenti FG, Amend WJ

Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection.

Clinical transplantation

Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJ, Stock PG, Melzer JS, Vincenti F

Phase II FK 506 multicenter concentration control study: one-year follow-up.

Transplantation proceedings

Laskow DA, Vincenti F, Neylan J, Mendez R, Matas A

The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.

Transplantation

Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, Melzer JS, Roberts JP, Tomlanovich SJ, Vincenti F

Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Artero ML, Sharma R, Savin VJ, Vincenti F

Pentoxifylline reduces the first-dose reactions following OKT3.

Transplantation proceedings

Vincenti FG, Vasconcelos M, Birnbaum JL, Tomlanovich SJ, Amend WJ, Melzer JS, Snyder JP

Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients.

Transplantation

Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C

Hepatitis C--its prevalence in end-stage renal failure patients and clinical course after kidney transplantation.

Transplantation

Stempel CA, Lake J, Kuo G, Vincenti F

Recurrent focal glomerulosclerosis: natural history and response to therapy.

The American journal of medicine

Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F

Cytokine and T cell receptor gene expression at the site of allograft rejection.

Transplantation

Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJ, Melzer J, Garovoy MR, Roberts JP

Hepatitis C virus in cadaver organ donors: prevalence and risk of transmission to transplant recipients.

Transplantation proceedings

Vincenti F, Weber P, Kuo G, Forsell J, Hunt S, Melzer J, Salvatierra O, Stempel C

Effect of cyclosporine on the clinical course of HBsAg-positive renal transplant patients.

Transplantation proceedings

Stempel C, Lake J, Ferrell L, Tomlanovich S, Amend W, Salvatierra O, Vincenti F

Improved results with combined donor-specific transfusion (DST) and sequential therapy protocol.

Transplantation proceedings

Salvatierra O, McVicar J, Melzer J, Amend W, Vincenti F, Tomlanovich S, Husing R, Rabkin J, Garovoy M

Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation.

Transplantation

Vincenti F, Biava C, Tomlanovitch S, Amend WJ, Garovoy M, Melzer J, Feduska N, Salvatierra O

Immunologic alterations induced by donor-specific transfusion.

Transplantation proceedings

Lockard-Marduel A, Gumbert M, Tomlanovich S, Amend W, Vincenti F, Schralla P, Melzer J, Feduska NJ, Salvatierra O, Garovoy MR

Successful management of the highly sensitized renal allograft recipient.

Transplantation proceedings

Melzer JS, Husing R, Lou C, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O

The incidence and impact of herpes simplex virus infections in the first month following renal transplantation.

Transplantation proceedings

Tomlanovich SJ, Sabatte-Caspillo J, Melzer J, Amend W, Vincenti F, Feduska N, Salvatierra O

Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipients.

Transplantation proceedings

Feduska NJ, Melzer JS, Amend WJ, Vincenti F, Tomlanovich SJ, Garovoy M, Husing R, Salvatierra O

How to improve results for second renal allografts.

Transplantation proceedings

Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Lou C, Salvatierra O

Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation?

Transplantation proceedings

Tomlanovich S, Vincenti F, Amend W, Biava C, Melzer J, Feduska N, Salvatierra O

Posttransplant renal rejection: comparison of quantitative scintigraphy, US, and MR imaging.

Radiology

Hricak H, Terrier F, Marotti M, Engelstad BL, Filly RA, Vincenti F, Duca RM, Bretan PN, Higgins CB, Feduska N

Donor-specific blood transfusions versus cyclosporine--the DST story.

Transplantation proceedings

Salvatierra O, Melzer J, Vincenti F, Amend WJ, Tomlanovich S, Potter D, Husing R, Garovoy M, Feduska NJ

Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?

Transplantation proceedings

Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O

Observations relating to the incidence of the acquired immune deficiency syndrome and other possibly associated conditions in a large population of renal transplant recipients.

Transplantation proceedings

Feduska NJ, Perkins HA, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Garovoy M, Salvatierra O

Sonography in the diagnosis of acute renal allograft rejection and cyclosporine nephrotoxicity.

AJR. American journal of roentgenology

Linkowski GD, Warvariv V, Filly RA, Vincenti F

The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipients.

Transplantation

Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O

Renal allograft rejection: US evaluation.

Radiology

Hoddick W, Filly RA, Backman U, Callen PW, Vincenti F, Hricak H, Mahony BS, Amend W

The clinical course of IgA-nephropathy and Henoch-Schönlein purpura following renal transplantation.

Transplantation

Bachman U, Biava C, Amend W, Feduska N, Melzer J, Salvatierra O, Vincenti F

Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.

Transplantation proceedings

Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O

Is a "low" dose of prednisone better than a "high" dose at the time of renal transplantation?

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

Stabile C, Vincenti F, Garovoy M, Duca R, Melzer J, Feduska NJ, Salvatierra O, Amend WJ

A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy.

Transplantation

Salvatierra O, Melzer J, Potter D, Garovoy M, Vincenti F, Amend WJ, Husing R, Hopper S, Feduska NJ

Pharmacokinetics of sulfisoxazole in renal transplant patients.

Antimicrobial agents and chemotherapy

Shermantine M, Gambertoglio J, Amend W, Vincenti F, Oie S

Dramatic improvement in the success rate for renal transplants in diabetic recipients with donor-specific transfusions.

Transplantation

Feduska NJ, Melzer J, Amend W, Vincenti F, Duca R, Garovoy M, Hopper S, Salvatierra O

Peptic ulcer disease in kidney transplant recipients.

American journal of surgery

Feduska NJ, Amend WJ, Vincenti F, Melzer JS, Duca R, Garovoy MR, Salvatierra O

Parathyroid and bone response of the diabetic patient to uremia.

Kidney international

Vincenti F, Arnaud SB, Recker R, Genant H, Amend WJ, Feduska NJ, Salvatierra O

Long-term renal function in kidney donors. Sustained compensatory hyperfiltration with no adverse effects.

Transplantation

Vincenti F, Amend WJ, Kaysen G, Feduska N, Birnbaum J, Duca R, Salvatierra O

The role of blood transfusions in renal transplantation.

The Urologic clinics of North America

Salvatierra O, Vincenti F, Amend WJ, Garovoy MR, Potter D, Feduska NJ

De novo and recurrent membranous glomerulopathy following kidney transplantation.

Transplantation

Berger BE, Vincenti F, Biava C, Amend WJ, Feduska N, Salvatierra O

Furosemide assays and disposition in healthy volunteers and renal transplant patients.

Federation proceedings

Benet LZ, Smith DE, Lin ET, Vincenti F, Gambertoglio JG

Urinary kallikrein excretion after renal transplantation: relationship to hypertension, graft source, and renal function.

The American journal of medicine

O'Connor DT, Barg AP, Amend W, Vincenti F

Blood transfusions before and on the day of transplantation: effects on cadaver graft survival.

Transplantation proceedings

Feduska NJ, Amend WJ, Vincenti F, Duca R, Salvatierra O

Update of the University of California at San Francisco experience with donor-specific blood transfusions.

Transplantation proceedings

Salvatierra O, Iwaki Y, Vincenti F, Amend W, Terasaki P, Garovoy M, Duca R, Hopper S, Feduska N

Blood transfusions and kidney transplantation.

Archives of internal medicine

Vincenti F, Amend WJ, Feduska NJ, Salvatierra O

Prednisone and prednisolone bioavailability in renal transplant patients.

Kidney international

Gambertoglio JG, Frey FJ, Holford NH, Birnbaum JL, Lizak PS, Vincenti F, Feduska NJ, Salvatierra O, Amend WJ

Prognostic features of early renal transplant rejections.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Amend WJ, Vincenti F, Duca R, Feduska NJ, Cochrum K, Potter D, Salvatierra O

Septic arthritis following renal transplantation.

Nephron

Vincenti F, Amend WJ, Feduska NJ, Salvatierra O

An alternative to cadaver kidney transplants for patients with insulin-dependent diabetes mellitus.

Transplantation

Feduska NJ, Vincenti F, Amend W, Iwaki Y, Opelz G, Terasaki P, Duca R, Hopper S, Salvatierra O

Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusions.

Transplantation

Salvatierra O, Iwaki Y, Vincenti F, Amend W, Potter D, Opelz G, Terasaki P, Duca R, Hopper S, Feduska N

Improved graft survival following donor-specific blood transfusions.

Transplantation proceedings

Cochrum K, Hanes D, Potter D, Perkins H, Amend W, Vincenti F, Iwaki Y, Opelz G, Terasaki P, Levin B, Sampson D, Feduska N, Salvatierra O

Prevention of prednisone-induced negative nitrogen balance. Effect of dietary modification on urea generation rate in patients on hemodialysis receiving high-dose glucocorticoids.

Annals of internal medicine

Cogan MG, Sargent JA, Yarbrough SG, Vincenti F, Amend WJ

Pretransplant cytotoxic antibodies do not segregate kidney transplant recipients into responder and non-responder groups.

Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association

Vincenti F, Amend W, Feduska N, Duca R, Salvatierra O

Immunologic factors determining survival of cadaver-kidney transplants. The effect of HLA serotyping, cytotoxic antibodies and blood transfusions on graft survival.

The New England journal of medicine

Vincenti F, Duca RM, Amend W, Perkins HA, Cochrum KC, Feduska NJ, Salvatierra O

The effect of hypothermic pulsatile perfusion on glomerular epithelial surface structures studied by scanning electron microscopy.

Transactions - American Society for Artificial Internal Organs

Vincenti F, Amend W, Feduska N, Maglio M, Axel L, Cochrum K, Salvatierra O

Search form

You are here

Flavio Vincenti, MD